Oldinot Duo
Combination of a selective and reversible acetylcholinesterase inhibitor and an antagonist of N-methyl-d-aspartate receptors (NMDA). Indicated to the treatment of moderate to severe Alzheimer-type dementia.
Therapeutic Area
Alzheimer
Active Ingredient
Donepezil + Memantine
Line
Neurosciences
Pharmaceutical Forms
10/14 mg controlled-release tablets x 30
10/28 mg controlled-release tablets x 30
